Featured

MVG Consulting Featured News

Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies

July 15th, 2021 | Featured

To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is comprised of a specialized group of experts, all of whom focus in a specific niche. The committee is centrally involved with the gene […]

With Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout

July 8th, 2021 | Featured

When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite positive trial data, the FDA is demanding that there be more evidence of the drug’s effect […]

We are Hiring – Open Contractor Positions at MVG Consulting

February 8th, 2021 | Featured

Looking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!

COVID-19 Heightens Call for Diversity within Biopharma

January 26th, 2021 | Featured

COVID-19, and its disproportionate effect on minority populations highlighted the need for increased diversity in clinical trials in order to adequately treat every patient population. The biopharma industry has resisted diversification in the past because its infrastructure breeds success in working within non-diverse populations. However, 2020, changed things, and the urgency to improve diversification is […]

Decentralized Clinical Trials: Here Comes the Future

January 20th, 2021 | Featured

Once a seemingly far-fetched endeavor, decentralized clinical trials are gaining favor in the wake of COVID-19. It has become clear that the time for entirely in-person clinical trials has passed, paving the way for a new, technologically integrated approach. This next year will be exceptionally telling as telemedicine and mobile health tracking continue to drive […]

MVG Teams up with World Computer Exchange

January 15th, 2021 | Featured

At the end of this uniquely challenging year, MVG Consulting would like to take a moment to thank those who have had an indelible impact throughout this difficult time. To the frontline workers, who have worked tirelessly, adapting to every changing circumstance this pandemic has forced upon us. To those working remotely, who have had to […]

How Covid-19 could drive a shift toward decentralized clinical trials

December 7th, 2020 | Featured

Heading towards the inevitable? COVID-19 paves the way for decentralized trials The pandemic has become a showcase for decentralized research that uses telemedicine and mobile tools to accelerate the pace of discovery. Source: How Covid-19 could drive a shift toward decentralized clinical trials

Virtual Pharma: How Technology is Paving the Way for Increased Innovation

November 23rd, 2020 | Featured

Technological innovation within the Pharmaceutical industry is on a clear path towards continued growth, and with that comes the opportunity for new players to get involved. Outside of speed and efficiency, the integration of technology also allows increased accessibility for companies perhaps not otherwise suited to infiltrate the industry. Virtual Pharma companies are a great […]

Rapid Scientific Innovation Begs the Question of Integrity

November 16th, 2020 | Featured

The speed with which COVID-19 vaccines are being developed leaves many uncertain about the safety and effectiveness of a potential vaccine. The global conference hosted by Harvard and MIT confronts this uncertainty and probes the question of how to evaluate and regulate drug development moving forward. Technology will play a central role in upcoming innovation, […]

Are You Paying More For Good Talent Than You Should? Maybe It’s Time To Try Contract Work

October 13th, 2020 | Featured

When it comes to hiring the right talent to help a company succeed, the tradition has typically been to hire full-time talent that can be groomed to the culture and processes of a specific firm. However, investing in full time employees is costly, and doesn’t always ensure the productivity necessary to make that investment worthwhile. Thankfully, […]

Pin It on Pinterest